Cargando…
A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study.
In this study we investigated whether a known delta-aminolevulinic acid dehydratase (ALAD) exon 4 polymorphism has a modifying effect on the association of blood or bone lead level with uricemia and indices of renal function among middle-aged and elderly men. We performed a cross-sectional study of...
Autores principales: | Wu, Ming-Tsang, Kelsey, Karl, Schwartz, Joel, Sparrow, David, Weiss, Scott, Hu, Howard |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241391/ https://www.ncbi.nlm.nih.gov/pubmed/12611663 |
Ejemplares similares
-
The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study.
por: Hu, H, et al.
Publicado: (2001) -
Role of δ-Aminolevulinic Acid Dehydratase (ALAD) gene polymorphism in lead induced nephrotoxicity
por: Tiwari, Mugdha, et al.
Publicado: (2014) -
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead.
por: Smith, C M, et al.
Publicado: (1995) -
Genetic Polymorphism of Delta Aminolevulinic Acid Dehydratase (ALAD) Gene and Symptoms of Chronic Mercury Exposure in Munduruku Indigenous Children within the Brazilian Amazon
por: Perini, Jamila Alessandra, et al.
Publicado: (2021) -
Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden.
por: Wetmur, J G
Publicado: (1994)